Nymox Provides Update on Recent Changes in Board and Management

Nymox Pharmaceutical Corporation has recently made significant changes to its board of directors and management, while also rejecting a potential transaction that was deemed not beneficial for the company and its shareholders. As part of these changes, Mr. Randall Lanham, former in-house legal counsel, and Mr. Christopher Riley, former chief financial officer, have been terminated from their pos..